Jingjing Zhou Selected Research

ferruginol

3/2021	Retracted: Ferruginol Diterpenoid Selectively Inhibits Human Thyroid Cancer Growth by Inducing Mitochondrial Dependent Apoptosis, Endogenous Reactive Oxygen Species (ROS) Production, Mitochondrial Membrane Potential Loss and Suppression of Mitogen-Activated Protein Kinase (MAPK) and PI3K/AKT Signaling Pathways.
1/2019	Ferruginol Diterpenoid Selectively Inhibits Human Thyroid Cancer Growth by Inducing Mitochondrial Dependent Apoptosis, Endogenous Reactive Oxygen Species (ROS) Production, Mitochondrial Membrane Potential Loss and Suppression of Mitogen-Activated Protein Kinase (MAPK) and PI3K/AKT Signaling Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingjing Zhou Research Topics

Disease

13	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 11/2014
10	Neoplasms (Cancer) 10/2022 - 01/2014
4	Fibrosis (Cirrhosis) 09/2020 - 01/2013
4	Pain (Aches) 01/2020 - 10/2017
3	Carcinogenesis 10/2020 - 07/2017
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2015 - 01/2013
2	Schizophrenia (Dementia Praecox) 03/2022 - 05/2016
2	Thrombosis (Thrombus) 01/2022 - 01/2018
2	Hemorrhage 01/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Infections 01/2022 - 09/2014
2	Thyroid Neoplasms (Thyroid Cancer) 03/2021 - 01/2019
2	Peritonitis 03/2021 - 11/2019
2	Proteinuria 01/2021 - 01/2013
2	Chronic Renal Insufficiency 01/2021 - 01/2013
2	Esophageal Neoplasms (Esophageal Cancer) 10/2020 - 11/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2019 - 01/2014
2	Disease Progression 12/2017 - 01/2017
2	Breast Neoplasms (Breast Cancer) 07/2017 - 01/2017
2	Atrophy 01/2014 - 01/2013
1	Varicose Veins (Varicose Vein) 10/2022
1	Pulmonary Arterial Hypertension 10/2022
1	Insulin Resistance 08/2022
1	Periodontitis 08/2022
1	Hyperglycemia 08/2022
1	Abscess 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pulmonary Hypertension 01/2022
1	Amyloid Plaque 01/2022
1	Medically Unexplained Symptoms 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Decompression Sickness (Bends) 12/2021
1	Wounds and Injuries (Trauma) 08/2021
1	Hemolysis 07/2021
1	Papillary Thyroid Cancer 03/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Esophageal Squamous Cell Carcinoma 10/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2014
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2014
6	Escitalopram FDA Link 01/2022 - 01/2019
4	NitrosaminesIBA 10/2022 - 11/2019
3	Biological ProductsIBA 08/2022 - 01/2016
3	Peptides (Polypeptides)IBA 01/2022 - 06/2017
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 12/2021
3	Pharmaceutical PreparationsIBA 10/2021 - 05/2016
3	MicroRNAs (MicroRNA)IBA 03/2021 - 01/2014
3	makatoxin I (BMK I)IBA 09/2019 - 10/2010
2	LipidsIBA 08/2022 - 03/2015
2	Streptozocin (Streptozotocin)FDA Link 08/2022 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 01/2022
2	Antimicrobial PeptidesIBA 01/2022 - 01/2022
2	Adenosine Diphosphate (ADP)IBA 01/2022 - 01/2022
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 10/2021
2	ferruginolIBA 03/2021 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 03/2021 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 01/2019
2	DiterpenesIBA 03/2021 - 01/2019
2	EnzymesIBA 03/2021 - 07/2017
2	ProteomeIBA 01/2021 - 09/2014
2	Fenofibrate (CiL)FDA LinkGeneric 05/2020 - 03/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2015
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 06/2017
2	Scopolamine (Hyoscine)FDA Link 01/2020 - 01/2019
2	CalciumIBA 11/2019 - 06/2019
2	Complement System Proteins (Complement)IBA 01/2015 - 01/2013
1	Environmental CarcinogensIBA 10/2022
1	desmuslin (synemin)IBA 10/2022
1	ArtesunateIBA 08/2022
1	Insulin (Novolin)FDA Link 08/2022
1	C-Reactive ProteinIBA 01/2022
1	Betaine (C.B.B.)FDA Link 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022
1	HydrogelsIBA 01/2022
1	Serum Amyloid P-ComponentIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	CopperIBA 12/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021
1	ningdongIBA 03/2021
1	Jelleine IIBA 03/2021
1	Therapeutic UsesIBA 03/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2021
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2021
1	Prorenin ReceptorIBA 01/2021
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2021
1	Paroxetine (Paxil)FDA LinkGeneric 01/2021

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2014
2	Drug Therapy (Chemotherapy) 10/2021 - 01/2019
1	Injections 01/2022
1	Intravenous Injections 10/2021
1	Aftercare (After-Treatment) 08/2021